The global surgical sealants and adhesives market is consolidated in nature. The market is dominated by Baxter International, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc., U.S.), CryoLife, Inc. (U.S.), and C. R. Bard, Inc. (U.S.) which together accounted for ~80–85% of the global market in 2015.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=38230314
The leading position of Johnson & Johnson (Ethicon, Inc., U.S.) in this market is majorly attributed to its strong product portfolio, wide geographic presence, and strong services network across the globe. The company offers a robust and broad product portfolio for surgical sealants and adhesives, which is an important factor for its large market share. Moreover, the company has a diversified revenue system, which helps it to sustain its leading position in the market. The company primarily focuses on increasing its presence in this market through continuous R&D to provide technologically advanced products to its customers.
To widen the product’s application areas, the company actively focuses on receiving regulatory approvals for its products across the U.S. and other regions. For instance, in October 2016, Ethicon received the U.S. FDA approval for extended indication of its EVARREST Fibrin Sealant Patch to be used as an adjunct to hemostasis for the control of bleeding during liver surgeries. Ethicon actively focuses on sustaining its market position as a leading sealant provider by expanding its presence across the globe. In this regard, in October 2016, Johnson & Johnson opened the new Global Services delivery center in Tampa (Florida) to expand its manufacturing and research capabilities in the market. Moreover, the company has maintained its leadership position in the market through its strong distribution networks across North America, Europe, Asia-Pacific, and the Rest of World.
Baxter International, Inc. (U.S.) held the second position in the global surgical sealants and adhesives market. The company specializes in providing medical devices, pharmaceuticals, and biotechnology products and is a major player in the global surgical sealants and adhesives market. The company emphasizes on organic growth strategies such as acquisitions and new product launches to enhance its market share. Baxter International, Inc. acquired Synovis Life Technologies, Inc. (U.S.), a medical device company in February 2012. The acquisition enabled the company to further strengthen its product portfolio for the biosurgery market. The company is one of the major players in the market due to its strong presence in the U.S. As of 2015, the U.S. contributed a major share of its revenue. In addition to this, Baxter has a presence in diverse markets across Europe, Asia, and other regions. Moreover, the company actively focuses on receiving regulatory approvals for its products across the U.S. and Europe. The company’s global footprint and the critical nature of its products and services play a key role in helping it garner a large share in this market.
C.R. Bard, Inc. (U.S.) held the third position in the global surgical sealants and adhesives market. The company has a strong presence in the U.S., Japan, and other countries. The company is focused on extending its biosurgery product portfolio through acquisitions. For instance, in September 2015, Bard entered into a definitive agreement to acquire Kobayashi Pharmaceutical Co., Ltd.’s 50% ownership share in Medicon, Inc. in Japan. In addition, in October 2012, C.R. Bard entered into an agreement to acquire NeoMed, Inc. (U.S.), a manufacturer and supplier of sprayable surgical sealants and anti-adhesion products. The company’s hydrogel-based sealant, Progel, is widely adopted by surgeons across the globe in thoracic surgeries, which in turn is responsible for the considerable market share of C.R. Bard in the global surgical sealants and adhesives market.
